These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8388215)

  • 1. The design of delta-selective opioid receptor antagonists.
    Portoghese PS
    Farmaco; 1993 Feb; 48(2):243-51. PubMed ID: 8388215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the side chain in determining relative delta- and kappa-affinity in C5'-substituted analogues of naltrindole.
    Black SL; Jales AR; Brandt W; Lewis JW; Husbands SM
    J Med Chem; 2003 Jan; 46(2):314-7. PubMed ID: 12519069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective delta-opioid receptor ligands: potential PET ligands based on naltrindole.
    Clayson J; Jales A; Tyacke RJ; Hudson AL; Nutt DJ; Lewis JW; Husbands SM
    Bioorg Med Chem Lett; 2001 Apr; 11(7):939-43. PubMed ID: 11294396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists.
    Ohkawa S; Portoghese PS
    J Med Chem; 1998 Oct; 41(21):4177-80. PubMed ID: 9767654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays.
    Palmer RB; Upthagrove AL; Nelson WL
    J Med Chem; 1997 Feb; 40(5):749-53. PubMed ID: 9057861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models.
    Metzger TG; Paterlini MG; Portoghese PS; Ferguson DM
    Neurochem Res; 1996 Nov; 21(11):1287-94. PubMed ID: 8947918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
    Portoghese PS; Sultana M; Nagase H; Takemori AE
    Eur J Pharmacol; 1992 Jul; 218(1):195-6. PubMed ID: 1327826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.
    Portoghese PS; Sultana M; Takemori AE
    J Med Chem; 1990 Jun; 33(6):1714-20. PubMed ID: 2160538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and delta-opioid receptor antagonist activity of a naltrindole analogue with a regioisomeric indole moiety.
    Portoghese PS; Ohkawa S; Moe ST; Takemori AE
    J Med Chem; 1994 Jun; 37(12):1886-8. PubMed ID: 8021929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton.
    Ishikawa K; Mochizuki Y; Hirayama S; Nemoto T; Nagai K; Itoh K; Fujii H
    Bioorg Med Chem; 2016 May; 24(10):2199-205. PubMed ID: 27079125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice.
    Portoghese PS; Farouz-Grant F; Sultana M; Takemori AE
    J Med Chem; 1995 Feb; 38(3):402-7. PubMed ID: 7853332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole.
    Coop A; Rothman RB; Dersch C; Partilla J; Porreca F; Davis P; Jacobson AE; Rice KC
    J Med Chem; 1999 May; 42(9):1673-9. PubMed ID: 10229636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.
    Gao P; Larson DL; Portoghese PS
    J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta 1 subtype.
    Lever JR; Stathis M; Kinter CM; Scheffel U
    Life Sci; 1996; 58(21):PL331-6. PubMed ID: 8637403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.
    Portoghese PS; Sultana M; Moe ST; Takemori AE
    J Med Chem; 1994 Mar; 37(5):579-85. PubMed ID: 8126697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
    Peng Y; Keenan SM; Zhang Q; Kholodovych V; Welsh WJ
    J Med Chem; 2005 Mar; 48(5):1620-9. PubMed ID: 15743203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives.
    Kutsumura N; Koyama Y; Nagumo Y; Nakajima R; Miyata Y; Yamamoto N; Saitoh T; Yoshida N; Iwata S; Nagase H
    Bioorg Med Chem; 2017 Aug; 25(16):4375-4383. PubMed ID: 28662966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-Desoxy analogues of naltrindole and 7-spiroindanyloxymorphone: the role of the 14-hydroxy group at delta opioid receptors.
    Kshirsagar TA; Fang X; Portoghese PS
    J Med Chem; 1998 Jul; 41(14):2657-60. PubMed ID: 9651172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of 3-substituted 3-desoxynaltrindole derivatives.
    Kubota H; Rothman RB; Dersch C; McCullough K; Pinto J; Rice KC
    Bioorg Med Chem Lett; 1998 Apr; 8(7):799-804. PubMed ID: 9871544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    Hammond DL; Stewart PE; Littell L
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.